以金属和金属化物为基础的林化合物的当前发展作为莱什曼杀伤剂
Edgar Del Carpio1, Lino Hernández2, Vito Lubes2
1Unidad de Química Medicinal, Facultad de Farmacia, Escuela "Dr. Jesús María Bianco", Universidad Central de Venezuela (UCV), Caracas, Venezuela.
Frontiers in chemistry
|June 16, 2025
概括
将金与金属/金属化物混合,可以产生强大的雷什曼杀伤剂. 本综述涵盖金属/金属化物-类化合物,详细说明它们在莱什曼病治疗中的结构-活性关系.
科学领域:
- 无机药用化学 无机药用化学
- 药品化学 药品化学 是一个
- 寄生虫学的寄生虫学
背景情况:
- 奇诺林支架对于开发莱什曼杀伤剂至关重要.
- 素与金属/金属化物混合生成的化合物对莱什曼病具有高度活性和选择性.
- 现有的化合物包括8-基酸协调化合物,金属衍生物和N-异环碳化合物 (NHC) 复合物.
研究的目的:
- 审查金属和金属化物基的氨酸化合物具有leishmanicidal活动.
- 专注于结构-性质关系,作用机制,以及体内/药物动力学数据.
- 突出用于莱什曼病药物开发的无机药物化学的最新技术.
主要方法:
- 关于金属/金属化物-类化合物的文献综述.
- 结构与财产关系的分析.
- 在体外和体内研究的总结,以及药物动力学数据.
主要成果:
- 将化合物分为三个主要组:8-基酸复合物,金属和NHC复合物.
- 在各种金属/金属化物-氨酸杂交物中证明了强烈的雷什曼尼cidal活性和选择性.
- 识别结构-活动关系,以指导进一步发展.
结论:
- 金属和金属化物-类化合物代表了开发新型莱什曼杀伤剂的有希望的战略.
- 对这些无机化合物的进一步研究可以导致对莱什曼病的更有选择性和更强效的治疗方法.
- 该综述为无机药物化学和寄生虫学研究人员提供了全面的概述.
相关概念视频
Metal-Ligand Bonds
21.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
21.5K
Properties of Organometallic Compounds
1.1K
Organometallic compounds are compounds that contain a carbon–metal bond. Carbon belongs to an organyl group like alkyl, aryl, allyl, or benzyl groups. The metal can be from Group I or Group II of the periodic table, a transition metal, or a semimetal.
1.1K
Extraction: Advanced Methods
552
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
552


